A call to action: Global Blood Therapeutics on tackling orphan disease
Pathfinders in Biopharma - Podcast autorstwa RBC Capital Markets
Kategorie:
What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.
